MIR200CHG and cancer: Although MIR200CHG is also upregulated in several other cancers (Supplementary Fig. 1b), it is downregulated in kidney renal clear cell carcinoma (KIRP), kidney renal papillary cell carcinoma (KIRC), and skin cutaneous melanoma (SKCM) (Supplementary Fig. 1c), indicating that MIR200CHG may function in a context-dependent manner.